Ultime notizie per Agritek Holdings (OTC:AGTK) Azioni

Agritek Holdings Inc is a U.S based fully integrated, active investor and operator in the legal cannabis sector. The company acquires and leases real estate, then leases or sub-leases the real estate to licensed marijuana operators. It is focused on three high-value segments of the cannabis market, including real estate investment, intellectual property brands; and infrastructure, with operations in three states: Colorado, Washington State, and California as well as Canada and Puerto Rico. The firm invests its capital through real estate holdings, licensing agreements, royalties, and equity in acquisition operations.

AGRITEK HOLDINGS INC by Agritek Holdings, Inc.

Agritek Holdings Inc

Cue Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUE#NASDAQ">CUE</a>) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.15) by 13.33 percent. This is a 32 percent increase over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $421.00 thousand which missed the analyst consensus estimate of $1.27 million by 66.79 percent. This is a 75.48 percent decrease over sales of $1.72 million the same period last year.

Earnings

Earnings Misses

News

Cue Biopharma Q1 EPS $(0.17) Misses $(0.15) Estimate, Sales $421.00K Miss $1.27M Estimate

Jasper Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JSPR#NASDAQ">JSPR</a>) reported quarterly losses of $(1.41) per share which missed the analyst consensus estimate of $(1.33) by 6.02 percent. This is a 36.89 percent decrease over losses of $(1.03) per share from the same period last year.

Jasper Therapeutics, Inc. - Class A Common Stock

JSPR

Jasper Therapeutics Q1 EPS $(1.41) Misses $(1.33) Estimate

RBOT

Vicarious Surgical Collaborates With UMass Memorial Medical Center To Support Adoption And Utilization Of Its Robotic System Through Perioperative Practices

GoPro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GPRO#NASDAQ">GPRO</a>) is looking for Q2 Adj EPS of $(0.11)-$(0.03) vs $(0.12) analyst estimate. sees sales of $135.000 million-$155.000 million vs $124.65 million analyst estimate.

Guidance

GPRO

GoPro Sees Q2 Adj EPS $(0.11)-$(0.03) vs $(0.12) Est; Sees Sales $135.000M-$155.000M vs $124.65M Est

NuScale Power Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) released its first-quarter results after Monday's closing bell. Here's a look at the key figures <a href="https://www.benzinga.com/pressreleases/25/05/b45359929/nuscale-power-reports-first-quarter-2025-results">from the quarter. </a>
The Details: NuScale Power reported quarterly revenue of $13.4 million, which beat the analyst consensus estimate of $4.26 million. The company said revenues were driven by its FEED Phase 2 project and its Technology License Agreement for the RoPower Doicești power plant.
NuScale ended the first quarter with cash, cash equivalents and short-term investments of $521.4 million.
Read Next: <a href="https://www.benzinga.com/25/05/45354683/tesla-probably-wont-make-money-on-ride-hailing-for-years-gary-black-says?utm_source=articleShare">Tesla Robotaxi Hopes Dashed By Uber, Lyft: No Fast Lane To Profits, Warns Investor Gary Black&nbsp;</a>
Quarterly operating expenses decreased by $2.3 million to $42.3 million, compared to $44.6 million in the prior year&#8217;s quarter. The decrease was primarily driven by lower research and development expenses, partially offset by higher general and administrative expenses as NuScale continued to transition from research and development to commercialization.
&#8220;In the first quarter, NuScale continued to take proactive steps to build on our leadership as the first and only SMR provider to receive NRC design approval,&#8221; said John Hopkins, CEO of NuScale Power.
&#8220;With 12 modules already in the manufacturing process, we further readied our supply chain to ensure we stay on course to achieve our 2030 delivery target. Alongside our exclusive commercialization partner ENTRA1 Energy, we are in advanced dialogue with several prospective customers across governments and industries, including data centers, utilities, coal plant operators transitioning to nuclear, and petrochemical and energy companies,&#8221; Hopkins added. 
SMR Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, NuScale Power stock was up 1.95% at $17.79 after-hours Monday.  
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45353123/quantum-stocks-are-hot-in-2025-biggest-movers-to-watch?utm_source=articleShare">Quantum Stocks Are Hot In 2025: Biggest Movers To Watch&nbsp;</a></li>
</ul>
Photo: Shutterstock

After-Hours Center

Movers

Tech

NuScale Power Reports Q1 Results: Details

Phunware (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHUN#NASDAQ">PHUN</a>) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.12) by 50 percent. This is a 45.45 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $688.00 thousand which beat the analyst consensus estimate of $674.75 thousand by 1.96 percent. This is a 25.30 percent decrease over sales of $921.00 thousand the same period last year.

Earnings Beats

PHUN

Phunware Q1 EPS $(0.18) Misses $(0.12) Estimate, Sales $688.00K Beat $674.75K Estimate

Team (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TISI#NYSE">TISI</a>) reported quarterly losses of $(3.31) per share. This is a 0.6 percent increase over losses of $(3.33) per share from the same period last year. The company reported $198.66 million in sales this quarter. This is a 0.47 percent decrease over sales of $199.60 million the same period last year.

TISI

Team Q1 Adj. EPS $(3.31) Up From $(3.33) YoY, Sales $198.66M Down From $199.60M YoY

Life360 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIF#NASDAQ">LIF</a>) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.08) by 162.5 percent. This is a 135.71 percent increase over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $103.62 million which beat the analyst consensus estimate of $101.63 million by 1.96 percent. This is a 32.47 percent increase over sales of $78.23 million the same period last year.

Life360 Q1 EPS $0.05 Beats $(0.08) Estimate, Sales $103.62M Beat $101.63M Estimate

General

GRAL

GRAIL Partners With athenahealth To Offer Healthcare Providers Streamlined Ordering of GRAIL's Galleri Multi-Cancer Early Detection Test

East West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) has outperformed the market over the past 5 years by 9.31% on an annualized basis producing an average annual return of 24.59%. Currently, East West Bancorp has a market capitalization of $13.17 billion. 
Buying $1000 In EWBC: If an investor had bought $1000 of EWBC stock 5 years ago, it would be worth $3,008.18 today based on a price of $95.57 for EWBC at the time of writing.
<h3>East West Bancorp's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747082714_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

EWBC

Here's How Much $1000 Invested In East West Bancorp 5 Years Ago Would Be Worth Today

Mobile Infrastructure (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BEEP#AMEX">BEEP</a>) affirms FY2025 sales outlook from $37.00 million-$40.00 million to $37.00 million-$40.00 million vs $38.18 million estimate.

Mobile Infrastructure Corporation Common Stock

BEEP

Mobile Infrastructure Affirms FY2025 Sales Guidance of $37.00M-$40.00M vs $38.18M Est

Pangaea Logistics Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANL#NASDAQ">PANL</a>) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.12) by 75 percent. This is a 121.43 percent decrease over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $122.80 million which missed the analyst consensus estimate of $128.45 million by 4.40 percent. This is a 17.23 percent increase over sales of $104.75 million the same period last year.

PANL

Pangaea Logistics Solns Q1 Adj. EPS $(0.03) Beats $(0.12) Estimate, Sales $122.80M Miss $128.45M Estimate

Oxbridge Re Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXBR#NASDAQ">OXBR</a>) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is a 86.67 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $692.00 thousand which beat the analyst consensus estimate of $654.00 thousand by 5.81 percent. This is a 653.60 percent increase over sales of $(125.00 thousand) the same period last year.

OXBR

Oxbridge Re Holdings Q1 EPS $(0.02), Inline, Sales $692.00K Beat $654.00K Estimate

CLEU

China Liberal Education Holdings Receives Nasdaq Staff Determination Notice

FiscalNote Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOTE#NYSE">NOTE</a>) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.09) by 77.78 percent. This is a 83.33 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $27.51 million which beat the analyst consensus estimate of $26.43 million by 4.11 percent. This is a 14.33 percent decrease over sales of $32.11 million the same period last year.

NOTE

FiscalNote Holdings Q1 Adj. EPS $(0.02) Beats $(0.09) Estimate, Sales $27.51M Beat $26.43M Estimate

Tonix Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>) reported quarterly losses of $(2.84) per share which beat the analyst consensus estimate of $(3.37) by 15.73 percent. This is a 99.51 percent increase over losses of $(576.00) per share from the same period last year. The company reported quarterly sales of $2.43 million which missed the analyst consensus estimate of $2.55 million by 4.75 percent. This is a 2.14 percent decrease over sales of $2.48 million the same period last year.

TNXP

Tonix Pharmaceuticals Q1 EPS $(2.84) Beats $(3.37) Estimate, Sales $2.43M Miss $2.55M Estimate

Akoya Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKYA#NASDAQ">AKYA</a>) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.20) by 60 percent. This is a 33.33 percent increase over losses of $(0.48) per share from the same period last year. The company reported quarterly sales of $16.64 million which missed the analyst consensus estimate of $19.95 million by 16.59 percent. This is a 9.32 percent decrease over sales of $18.35 million the same period last year.

AKYA

Akoya Biosciences Q1 EPS $(0.32) Misses $(0.20) Estimate, Sales $16.64M Miss $19.95M Estimate

NET Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPWR#NYSE">NPWR</a>) reported quarterly losses of $(1.55) per share. This is a 868.75 percent decrease over losses of $(0.16) per share from the same period last year.

NPWR

NET Power Q1 2025 GAAP EPS $(1.55) Down From $(0.16) YoY

MagnaChip Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MX#NYSE">MX</a>) sees Q2 sales of $45.000 million-$49.000 million vs $44.50 million analyst estimate.

MagnaChip Semiconductor Sees Q2 Sales $45.000M-$49.000M vs $44.50M Est

Sonim Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONM#NASDAQ">SONM</a>) reported quarterly earnings of $0.08 per share. This is a 112.31 percent increase over losses of $(0.65) per share from the same period last year. The company reported $16.72 million in sales this quarter. This is a 0.33 percent decrease over sales of $16.78 million the same period last year.

Comments

Agritek Holdings

Notizie

Ultime notizie per Agritek Holdings (OTC:AGTK) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO